Therese Bittermann, MD, MSCE

faculty photo
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.

Description of Research Expertise

I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, the effects of transplant policy-making and center variability in patient care. These efforts have spanned adult and pediatric transplant populations. I also have research interests in autoimmune hepatitis and alcohol-associated liver disease. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.

Selected Publications

Bittermann T, Yagan L, Kathawate RG, Weinberg EM, Peyster EG, Lewis JD, Levy C, Goldberg DS: Real-world evidence for factors associated with maintenance treatment practices among U.S. adults with autoimmune hepatitis Hepatology Epub , Jun 2024.

Wang RX, Lee JJ, Mirda D, Hao J, Goebel AM, Deutsch-Link S, Serper M, Bittermann T: Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction-associated steatotic liver disease Liver Transplantation Epub ahead of print, Jun 2024.

Mezochow AK, Schaubel DE, Peyster EG, Lewis JD, Goldberg DS, Bittermann T: Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries. Transplant Infectious Diseases Epub ahead of print, Jun 2024.

Rosenthal BE, Abt PL, Reddy KR, Bittermann T: The role of exception points in outcomes of patients with fibrocystic liver-kidney disease: Implications for the National Liver Review Board. Liver Transplantation 30(5): 555-8, May 2024.

Cywes C, Banker A, Munoz N, Levine M, Abu-Gazala S, Bittermann T, Abt P: The Potential Utilization of Machine Perfusion to Increase Transplantation of Macrosteatotic Livers. Transplantation Epub ahead of print, May 2024.

Kapln A, Aby ES, Scott S, Sonnenday C, Fox A, Mathur A, Olthoff K, Heimbach J, Ladin K, Emamaullee J, NALLDIG Consortium: Financial toxicity in living donor liver transplantation: A call to action for financial neutrality American Journal of Transplantation Epub ahead of print, May 2024.

Bittermann T, Goldberg DS, Rudel RK, Byhoff E: Liver disease etiology and race/ethnicity are associated with neighborhood food insecurity risk in US liver transplant candidates Liver Transplantation Epub ahead of print, Apr 2024.

Rosenthal BE, Bittermann T: Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation? Liver Transplantation 30(4): 345-6, Apr 2024.

Hirshorn RE, Schaubel DE, Abt PL, Reddy KR, Bittermann T: Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era Liver Transplantation 30(4): 446-50, Apr 2024.

Ibeabuchi T, Li E, Bittermann T, Mahmud N, Abt PL: Reply: How does ex vivo liver perfusion help improve the outcomes of liver transplantation in donation after cardiac death donors? Liver Transplantation 30(3): E20-21, Mar 2024.

back to top
Last updated: 06/18/2024
The Trustees of the University of Pennsylvania